JC
Insider
Jason V Coloma
Chief Executive OfficerJason V Coloma (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $908K of MAZE (30,311 sh × $29.95, as filed), executed Jul 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.8M
shares × price, as filed
Last traded
Sep 3
Filed Sep 4
Median ADV $16.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
MAZERecent filings
MAZESALE
Maze Therapeutics, Inc.
View filing →
$553K21,134 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $783K
30,086 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET